<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Vet. Sci.</journal-id>
<journal-title>Frontiers in Veterinary Science</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Vet. Sci.</abbrev-journal-title>
<issn pub-type="epub">2297-1769</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fvets.2022.843792</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Veterinary Science</subject>
<subj-group>
<subject>Case Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Case Report: Tricuspid Annuloplasty for Right-Sided Congestive Heart Failure Secondary to Pulmonary Hypertension in a Dog</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Mizuno</surname> <given-names>Takeshi</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1595785/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Sasaki</surname> <given-names>Kenta</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1613431/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Suzuki</surname> <given-names>Sayaka</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Nagao</surname> <given-names>Itsuma</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1642042/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Isayama</surname> <given-names>Noriko</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1230211/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Veterinary Medical Center, Graduate School of Agricultural and Life Sciences, The University of Tokyo</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country></aff>
<aff id="aff2"><sup>2</sup><institution>Ve. C. Jiyugaoka Animal Medical Center</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country></aff>
<aff id="aff3"><sup>3</sup><institution>Uenonomori Animal Hospital</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country></aff>
<aff id="aff4"><sup>4</sup><institution>Japan Small Animal Medical Center</institution>, <addr-line>Saitama</addr-line>, <country>Japan</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: J. Alberto Montoya-Alonso, University of Las Palmas de Gran Canaria, Spain</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: La&#x000ED;n Garc&#x000ED;a-Guasch, Hospital Veterinari Molins, Spain; Luigi Venco, Clinica Veterinaria Lago Maggiore, Italy</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Takeshi Mizuno <email>snow.white0412&#x00040;gmail.com</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Veterinary Surgery and Anesthesiology, a section of the journal Frontiers in Veterinary Science</p></fn></author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>02</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>9</volume>
<elocation-id>843792</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>12</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>01</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2022 Mizuno, Sasaki, Suzuki, Nagao and Isayama.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Mizuno, Sasaki, Suzuki, Nagao and Isayama</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license></permissions>
<abstract>
<p>An 11-year-old, 12.3-kg, female Miniature Dachshund was presented to our institution with ascites of unknown etiology. The dog had been administered moxidectin for 3 years to treat a heartworm infection. Thoracic radiographs showed enlargement of the right heart. Echocardiography revealed right atrial and ventricular dilatation as well as flattening of the interventricular septum. Heartworm was identified in the main pulmonary artery, which was dilated. Tricuspid regurgitation (TR) was observed using color Doppler ultrasonography, and 2.5 L of ascites were removed. The dog was diagnosed with pulmonary hypertension, severe TR, and right-sided congestive heart failure. Except at the initial site, heartworm was not detected using echocardiography, and the antigen test was negative. However, pharmacological treatment did not improve the right-sided congestive heart failure. Instead, De Vega tricuspid annuloplasty (TAP) was performed on the beating heart under cardiopulmonary bypass with the owner&#x00027;s consent. Sutures terminated between the two commissures in the middle of the annulus and were secured using another pledget. Annular reduction was performed by tying down the plication suture while the cylindrical sizer was inserted into the tricuspid valve orifice. The size of the cylindrical sizer was 16 mm, which was set based on the height and width of the septal leaflet. A 6-month follow-up showed a reduction of TR and right-sided volume overload with no evidence of ascites retention/recurrence or any other complication. Our findings indicate that TAP may be a valid treatment option for dogs with right-sided congestive heart failure caused by secondary TR.</p></abstract>
<kwd-group>
<kwd>De Vega annuloplasty</kwd>
<kwd>cardiopulmonary bypass</kwd>
<kwd>tricuspid regurgitation</kwd>
<kwd>ascites</kwd>
<kwd>dog</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="27"/>
<page-count count="7"/>
<word-count count="4613"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Pulmonary hypertension (PH) leads to pressure overload in the right ventricle (RV), which induces right ventricular concentric and eccentric hypertrophy (<xref ref-type="bibr" rid="B1">1</xref>&#x02013;<xref ref-type="bibr" rid="B4">4</xref>). Right ventricular eccentric hypertrophy can cause tricuspid regurgitation (TR) <italic>via</italic> annulus dilatation (<xref ref-type="bibr" rid="B1">1</xref>&#x02013;<xref ref-type="bibr" rid="B4">4</xref>). Consequently, right-sided congestive heart failure (R-CHF) may develop (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). The efficacy of therapy for dogs with PH is limited by the occurrence of right ventricular dysfunction, which results in a tricuspid annular plane systolic excursion (TAPSE) of &#x0003C;3.23 mm/kg<sup>0.284</sup> or R-CHF (<xref ref-type="bibr" rid="B2">2</xref>). In human medicine, isolated TR secondary to PH is indicated for surgical treatment if the patient has symptoms of R-CHF (<xref ref-type="bibr" rid="B5">5</xref>). However, there are no guidelines for the treatment of TR in veterinary medicine. Furthermore, there are no reports of surgical treatment for acquired TR in dogs, although there are reports of surgical treatment for tricuspid dysplasia (<xref ref-type="bibr" rid="B6">6</xref>&#x02013;<xref ref-type="bibr" rid="B8">8</xref>). To the best of our knowledge, this is the first report of a successful surgical tricuspid annuloplasty (TAP) performed in a dog with TR acquired secondarily to PH. In this report, we describe the successful treatment of TR secondary to PH using De Vega annuloplasty under cardiopulmonary bypass (CPB) in a dog.</p></sec>
<sec id="s2">
<title>Case Presentation</title>
<p>An 11-year-old, 12.3-kg female Miniature Dachshund was presented to our institution to investigate and treat ascites of unknown etiology. The dog was diagnosed with filariasis at a primary hospital 3 years before presentation at our facility, for which moxidectin was continuously administered in the intervening period. Cardiac disease was thought to be the cause of the ascites, for which benazepril (0.2 mg/kg, BID) and pimobendan (0.12 mg/kg, BID) were prescribed at the primary hospital 4 months prior to presentation. The owners reported that the general condition of the dog was good. During the initial physical examination, the dog showed marked abdominal distension and a grade 2 systolic murmur over the right cardiac apex was noted.</p>
<sec>
<title>Diagnostic Assessment, Therapeutic Interventions, and Outcomes</title>
<p>Radiographic evaluation of the thorax indicated right heart enlargement. Two-dimensional echocardiography showed right atrial and ventricular dilatation (<xref ref-type="fig" rid="F1">Figure 1A</xref>). The septal leaflet of the tricuspid valve appeared slightly prolapsed. Flattening of the interventricular septum was also observed (<xref ref-type="fig" rid="F1">Figure 1B</xref>). The main pulmonary artery was dilated (main pulmonary artery/aortic diameter = 1.42, reference range &#x0003C;1.0) (<xref ref-type="bibr" rid="B9">9</xref>). Echoes coming from filarial worms in the main pulmonary artery were identified (<xref ref-type="fig" rid="F1">Figure 1C</xref>). Enlargement of the tricuspid valve annulus and a concomitant loss of coaptation were noted (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Continuous wave Doppler examination of the tricuspid valve returned a dagger-shaped regurgitant signal characteristic of severe TR (<xref ref-type="fig" rid="F1">Figures 1D,E</xref>). The signal indicates a sharp decrease in the pressure gradient between the right atrium (RA) and RV and consequent elevation of right atrial pressure (<xref ref-type="bibr" rid="B10">10</xref>). The distensibility index of the right pulmonary artery was reduced (18.4%, reference range &#x0003E;35%) (<xref ref-type="bibr" rid="B11">11</xref>). The acceleration time (AT) was shortened, and the acceleration time/ejection time (AT/ET) ratio was reduced (AT = 50 ms, reference range 52&#x02013;58 ms; AT/ET = 0.16, reference range &#x0003E;0.3) (<xref ref-type="bibr" rid="B1">1</xref>). The caudal vena cava collapse index was as low as 19% (<xref ref-type="bibr" rid="B12">12</xref>). A 2.5 L volume of ascites was removed. There was no evidence of respiratory disease or left-to-right shunting causing right ventricular enlargement. In addition, left-sided cardiac disease as a cause of post-capillary PH was not identified. Clinical findings and the clinical history supported a diagnosis of PH and secondary TR along with R-CHF.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Echocardiographic images generated at initial presentation. <bold>(A)</bold> Right parasternal long-axis and <bold>(B)</bold> short-axis papillary muscle levels of the heart. <bold>(C)</bold> Left parasternal short-axis view of the heart. <bold>(D)</bold> Color Doppler image showing tricuspid regurgitation (TR) from a left apical, four-chamber view of the heart. <bold>(E)</bold> Continuous wave Doppler signal of the TR. <bold>(A,B)</bold> Right atrial and right ventricular dilatation and flattening of the interventricular septum was observed. <bold>(C)</bold> Heartworms were identified in the main pulmonary artery (arrowhead). <bold>(D)</bold> Severe TR was present. <bold>(E)</bold> Continuous wave Doppler examination of the tricuspid valve showing the characteristic dagger-shaped regurgitant signal. LV, left ventricle; PV, pulmonic valve; RA, right atrium; RV, right ventricle; RVOT, right ventricular outflow tract.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fvets-09-843792-g0001.tif"/>
</fig>
<p>Melarsomine is not available in Japan, and moxidectin had already been prescribed for 3 years leading up to initial presentation. Therefore, sildenafil and torsemide were prescribed as treatments for the PH and R-CHF. Despite the volume overload caused by TR and resultant right-sided congestive heart failure, the TAPSE value was low (2.8 mm/kg<sup>0.284</sup>) (<xref ref-type="bibr" rid="B2">2</xref>). Considering this, we concluded that the right ventricular systolic function was compromised, and we also prescribed pimobendan. Despite increasing the medication dosages [sildenafil (2.4 mg/kg per os, twice daily), pimobendan (0.25 mg/kg per os, twice daily), and torsemide (0.16 mg/kg per os, twice daily)], no improvement in R-CHF was observed. Removal of 2 L of ascites was required approximately every 2 weeks. On the 175th day of follow-up, the dog&#x00027;s activity and appetite decreased, and her general condition deteriorated. Echocardiographic data revealed persistent PH and right-sided volume overload. Except at the initial site, heartworm was not detected using echocardiography, and a heartworm antigen test was negative. In this case, the dog exhibited R-CHF rather than PH symptoms (e.g., syncope). Therefore, we determined volume overload caused by TR to be the main clinical concern. TAP under CPB was recommended. After obtaining the owner&#x00027;s consent, the surgical procedure was performed 221 days after initial presentation.</p>
<p>The anesthesia protocol used was the same as that described in a previous report (<xref ref-type="bibr" rid="B13">13</xref>). In preparation for CPB, the right carotid artery was surgically isolated. A right thoracotomy was performed at the 5th intercostal space after administering an intercostal nerve block with bupivacaine hydrochloride. The cranial and caudal vena cava were isolated and encircled with umbilical tape. A purse-string, 5-0 polypropylene suture was placed on the cranial and caudal aspect of the RA, respectively. The azygous vein was isolated and temporarily occluded with umbilical tape. Subsequently, heparin sodium (300 U/kg) was administered intravenously. After 5 min, the activated clotting time was measured and confirmed to be &#x0003E;300 s. An 8-Fr CPB cannula (Flexmate, Toyobo, Shiga, Japan) was inserted into the carotid artery to serve as the arterial line for the CPB. For venous return, a 12-Fr and 14-Fr CPB cannula (DLP Cardiopulmonary Bypass Cannula, Medtronic, Tokyo, Japan) was inserted into the cranial and caudal vena cava <italic>via</italic> the RA, respectively. CPB was achieved using a heart-lung machine (HAS-II, Senko Medical Instrument, Tokyo, Japan) with an extracorporeal circuit, venous reservoir, and membrane oxygenator (Exelung Kids, Senko Medical Instrument, Tokyo, Japan). After the air was removed from the CPB circuit and the activated clotting time was prolonged to 408 s, a partial CPB was initiated, and the dog&#x00027;s body temperature dropped to 28&#x000B0;C. Blood flow was set at 50&#x02013;100 mL/kg/min on the CPB pump, and the cranial and caudal vena cava were occluded to initiate total CPB.</p>
<p>Using a right atriotomy approach, intracardiac procedures were performed on the beating heart without administering cardioplegic solution. An incision was made from the RA to the right atrial appendage. The tricuspid valve was viewed through the opened RA (<xref ref-type="fig" rid="F2">Figures 2A</xref>, <xref ref-type="fig" rid="F3">3A</xref>), and two filarial worms were removed from the RV. There was no elongation of the chordae tendineae in the septum of the tricuspid valve or anterior and posterior leaflets, and no mobility problems were observed (<xref ref-type="fig" rid="F3">Figures 3A,B</xref>). Chordal reconstruction was deemed unnecessary, and only TAP using the De Vega technique was performed.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Diagrammatic representation of the procedure for De Vega tricuspid annuloplasty. The size of the cylindrical sizer was 16 mm, which was set based on the height and width of the septal leaflet (17 and 14 mm, respectively).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fvets-09-843792-g0002.tif"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Intraoperative images. <bold>(A)</bold> The tricuspid valve was confirmed through the opened right atrium. <bold>(B)</bold> There was no elongation of the chordae tendineae in the tricuspid valve septum (arrowhead) or anterior and posterior leaflets, and no mobility problems were observed. <bold>(C)</bold> De Vega annuloplasty was performed with a CV-5 extended polytetrafluoroethylene suture. <bold>(D)</bold> Annular reduction was performed by tying down the plication suture while the cylindrical sizer was inserted into the tricuspid valve orifice. <bold>(E)</bold> The size of the cylindrical sizer (&#x0002A;) was 16 mm, which was set based on the height and width of the septal leaflet. <bold>(F)</bold> A regurgitation test after tricuspid annuloplasty was performed using saline, and the tricuspid valve was confirmed to be well closed. SL, septal leaflet.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fvets-09-843792-g0003.tif"/>
</fig>
<p>The De Vega annuloplasty was performed using CV-5 extended polytetrafluoroethylene (e-PTFE) sutures (GORE-TEX Suture, W.L. Gore &#x00026; Associates, Newark, NJ). One e-PTFE suture with an e-PTFE pledget was started at the anteroseptal commissure and placed around the anterior aspect of the valve (<xref ref-type="fig" rid="F2">Figures 2B,C</xref>). Another identical suture was started over the septal annulus, &#x0007E;5 mm beyond the posteroseptal commissure, and placed around the lateral aspect of the valve (<xref ref-type="fig" rid="F2">Figure 2D</xref>). Both sutures terminated between the two commissures in the middle of the annulus and were secured using another ePTFE pledget (<xref ref-type="fig" rid="F2">Figure 2E</xref>). Annular reduction was performed by tying down the plication suture while the cylindrical sizer was inserted into the tricuspid valve orifice (<xref ref-type="fig" rid="F3">Figures 3C,D</xref>). The size of the cylindrical sizer was 16 mm, which was set based on the height and width of the septal leaflet (17 and 14 mm, respectively; <xref ref-type="fig" rid="F2">Figures 2A,E</xref>, <xref ref-type="fig" rid="F3">3E</xref>). A regurgitation test after TAP was performed using saline, and closure of the tricuspid valve was confirmed (<xref ref-type="fig" rid="F3">Figure 3F</xref>). The RA incision was closed using continuous sutures of 6-0 polypropylene (Oval M, Matsudaika Kogyo, Tokyo, Japan). The dog&#x00027;s body temperature was brought back to 37&#x000B0;C, and CPB flow was gradually reduced before being completely turned off. Once the CPB was discontinued and the blood pressure was stable, the catheters were removed from the cranial and caudal vena cava and right carotid artery. A chest tube was inserted through the chest wall, and the cervical and thoracic incisions were closed using standard methods. To antagonize the effects of heparin, 4.5 mg/kg of protamine sulfate was administered intravenously over 30 min. Adequate blood pressure, oxygenation, and ventilation was then confirmed, and the anesthesia was reversed. The mean pre-operative venous pressure of 18 mmHg was decreased to 7 mmHg post-operatively. The durations of extracorporeal circulation, operation, and anesthesia were 70, 187, and 292 min, respectively. The dog recovered well with no anesthesia-related complications, and post-operative echocardiography revealed a reduction in tricuspid regurgitation. The dog was discharged on the eighth post-operative day and prescribed clopidogrel (2 mg/kg per os, once daily for 3 months), rivaroxaban (0.8 mg/kg per os, once daily for 1 week), sildenafil (2.1 mg/kg per os, twice daily), and pimobendan (0.2 mg/kg per os, twice daily).</p>
<p>Follow-up evaluations using echocardiography and chest radiography were performed at 1, 3, and 6 months after surgery.</p>
<p>At the 1-month follow-up, no ascites was observed, and the dog&#x00027;s condition was stable. Echocardiography showed good coaptation of the tricuspid valve and less interventricular septal flattening than was observed during the pre-operative period (<xref ref-type="fig" rid="F4">Figures 4D,E</xref>). The eccentricity index in diastole was decreased (1.34) compared with the measurement taken during the pre-operative period (2.19). The right ventricular end-diastolic volume was reduced from 11.6 cm<sup>2</sup> before surgery to 7.3 cm<sup>2</sup>. Color Doppler ultrasonography revealed minor tricuspid regurgitation, which was a notable improvement when compared with the pre-operative findings (<xref ref-type="fig" rid="F4">Figures 4A,B</xref>). Compared with the pre-operative recordings, the post-operative fractional area change (FAC) and TAPSE values had decreased from 51.3 to 33.0% and 5.80 to 2.56 mm, respectively. There were no findings suspicious for thrombus formation.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Pre-operative vs. post-operative transthoracic echocardiographic images. The 2-D color Doppler image of the tricuspid regurgitant jet obtained through the left apical imaging window <bold>(A&#x02013;C)</bold> and of the flattening of the interventricular septum obtained using right parasternal short-axis views <bold>(D&#x02013;F)</bold>.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fvets-09-843792-g0004.tif"/>
</fig>
<p>At the 6-month follow-up, the ascites had been completely resolved, and the owner reported that the dog&#x00027;s general condition was good. Echocardiography revealed mild tricuspid regurgitation (<xref ref-type="fig" rid="F4">Figures 4C,F</xref>), but the sizes of the RA and RV had not changed from 1-month follow-up (right ventricular end-diastolic volume = 7.3 cm<sup>2</sup>). The FAC and TAPSE values were 32% and 2.36 mm, respectively. Although there were improvements in the echocardiographic indices for PH, the presence or absence of PH could not be accurately assessed at follow-up because of reduced RV contractility. Therefore, we continued the treatment for PH beyond the 6-month follow-up. The dose of sildenafil was reduced to 1 mg/kg per os, twice daily, and pimobendan was continued at the same dose (0.2 mg/kg orally twice a day).</p></sec></sec>
<sec sec-type="discussion" id="s3">
<title>Discussion</title>
<p>In human medicine, there are reports and guidelines regarding TAP for patients with isolated TR secondary to PH (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). However, there are no guidelines for the treatment of TR in veterinary medicine, and there are no reports of surgical intervention for acquired TR. In the current case, tricuspid valve annulus dilatation with a concomitant loss of coaptation were noted, but the prolapse of the tricuspid valve was mild. Thus, we decided on a diagnosis of TR secondary to PH. Volume overload caused by TR was favored over persistent heartworm infection as the primary clinical concern for the following reasons: the infection was no longer detectable using echocardiography except for at the initial site and pre-operative antigen tests were negative. Right-sided congestive heart failure caused by TR became refractory to medical management. Therefore, surgery for TR was recommended, and TAP was performed. Accompanying the post-operative decrease in TR, venous pressure also decreased, the ascites was resolved, and the patient&#x00027;s general condition improved. In this case, TAP was clinically successful and resulted in good patient outcome. Considering this, TAP may be an effective treatment for dogs with R-CHF caused by secondary TR.</p>
<p>In human medicine, TAPSE &#x0003C;17 mm has been associated with poor prognosis in patients with secondary TR (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). Human patients with right ventricular dysfunction are indicated for surgery following careful consideration. In dogs, right ventricular dysfunction should also be carefully considered before initiating surgical intervention. However, there is a paucity of supporting evidence in veterinary medicine compared with in human medicine. Although pre-operative FAC was within the reference range in this case, there was concern about impairment of right ventricular function given the state of volume overload. The post-operative FAC was below the reference value, and the TAPSE was also reduced compared with pre-operative measurements (<xref ref-type="bibr" rid="B16">16</xref>). No post-operative complications occurred in this case because the surgery was performed on a beating heart out of concern for the possible right-heart dysfunction. However, the degree of right-heart dysfunction should always be determined as a measure of tolerance for surgical intervention in canine TR cases.</p>
<p>In this case, a De Vega rather than band annuloplasty was selected because the De Vega approach shortens the operation time and obtains good outcomes (<xref ref-type="bibr" rid="B8">8</xref>). De Vega annuloplasty has been shown to be effective and durable in the treatment of mitral regurgitation in dogs and has been performed in many cases (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>). However, use of this method for tricuspid valve surgery in dogs has not yet been reported. In human medicine, De Vega annuloplasty is useful for correcting functional TR with low long-term recurrence rates (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B19">19</xref>&#x02013;<xref ref-type="bibr" rid="B22">22</xref>). In human patients, the target annulus diameter is decided using an index calculated according to body surface area. This is done to avoid annuloplasty-related tricuspid stenosis and TR recurrence (<xref ref-type="bibr" rid="B23">23</xref>). However, there is no such index for tricuspid annuloplasty in dogs. Considering the possibility that annuloplasty may reduce the post-operative mobility of the anterior and posterior leaflets, the target tricuspid annulus diameter was set based on the height and width of the septal leaflet in this case. As a result, TR was well controlled. Further study is needed to examine and establish the appropriate annulus diameter for De Vega annuloplasty in canine patients. Expanded polytetrafluoroethylene sutures were used with the that expectation suture breakdown and dehiscence (the so-called bow-string effect) could be prevented (<xref ref-type="bibr" rid="B24">24</xref>), although evidence to this effect is lacking. Nishida et al. reported that e-PTFE has excellent tissue compatibility and durability and can be effectively used for canine mitral valve repair (<xref ref-type="bibr" rid="B25">25</xref>). In addition, we have recently used e-PTFE for mitral valve annuloplasty with good outcome (data not shown). In the present case, use of e-PTFE controlled the TR for 6 months, without breakdown of the suture annuloplasty. Overall, De Vega annuloplasty was useful for the treatment of TR in our canine patient. In conclusion, TAP may be a valid treatment option for TR acquired secondarily to PH in dogs.</p></sec>
<sec id="s4">
<title>Limitations</title>
<p>A limitation of this study is about the indication of TAP for dogs with heartworm. TAP may also be a viable treatment option for TR secondary to PH. However, Calvert et al. reported no correlation between the number of infiltrating heartworms and pulmonary vascular resistance, indicating that host&#x02013;parasite interactions play significant roles in the severity of disease (<xref ref-type="bibr" rid="B26">26</xref>). We acknowledge the possibility that removing the two heartworms intraoperatively may have contributed to clinical improvement. In this case, we could not perform adulticide therapy because melarsomine is unavailable in Japan. Pharmacological treatment may be prioritized over surgical intervention in environments where melarsomine is available. In dogs with heartworm, it is reported that once the endarteritis has developed, the vascular changes are chronic and may not be reversible (<xref ref-type="bibr" rid="B27">27</xref>). The reduction of TR cannot improve pulmonic vascular changes. Therefore, considering the consequences of heartworm in the pulmonary vasculature, it should be considered whether this surgery is an adequate therapeutic option for dogs with TR associated to PH in dogs with heartworm. Our findings suggest that TAP for TR with heartworm should be carefully considered when only treatments other than melarsomine are available. In the future, a more accurate evaluation of the efficacy of TAP will be supported by the performance of TAP in cases of TR secondary to PH with different etiologies.</p></sec>
<sec sec-type="data-availability" id="s5">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.</p></sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>Ethical review and approval were not required for the animal study because this is a case report. Written informed consent was obtained from the owners for the participation of their animals in this study.</p></sec>
<sec id="s7">
<title>Author Contributions</title>
<p>TM contributed to the conception and design of the work, analyzing the data, and writing the manuscript. KS and NI assisted with surgery and were involved with the aftercare and data acquisition. SS performed the general anesthesia. IN assisted with the pre-operative care. All authors contributed to the writing, editing, critical review, and approved the final version of the manuscript.</p></sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec sec-type="disclaimer" id="s8">
<title>Publisher&#x00027;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec></body>
<back>
<ack><p>The authors would like to thank Toshihiro Igarashi for the advice on the management of cardiopulmonary bypass and Editage (<ext-link ext-link-type="uri" xlink:href="http://www.editage.com">www.editage.com</ext-link>) for the English language editing of this manuscript.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reinero</surname> <given-names>C</given-names></name> <name><surname>Visser</surname> <given-names>LC</given-names></name> <name><surname>Kellihan</surname> <given-names>HB</given-names></name> <name><surname>Masseau</surname> <given-names>I</given-names></name> <name><surname>Rozanski</surname> <given-names>E</given-names></name> <name><surname>Clercx</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs</article-title>. <source>J Vet Intern Med.</source> (<year>2020</year>) <volume>34</volume>:<fpage>549</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1111/jvim.15725</pub-id><pub-id pub-id-type="pmid">32065428</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Visser</surname> <given-names>LC</given-names></name> <name><surname>Wood</surname> <given-names>JE</given-names></name> <name><surname>Johnson</surname> <given-names>LR</given-names></name></person-group>. <article-title>Survival characteristics and prognostic importance of echocardiographic measurements of right heart size and function in dogs with pulmonary hypertension</article-title>. <source>J Vet Intern Med.</source> (<year>2020</year>) <volume>34</volume>:<fpage>1379</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1111/jvim.15826</pub-id><pub-id pub-id-type="pmid">32501601</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohad</surname> <given-names>DG</given-names></name> <name><surname>Lenchner</surname> <given-names>I</given-names></name> <name><surname>Bdolah-Abram</surname> <given-names>T</given-names></name> <name><surname>Segev</surname> <given-names>G</given-names></name></person-group>. <article-title>A loud right-apical systolic murmur is associated with the diagnosis of secondary pulmonary arterial hypertension: retrospective analysis of data from 201 consecutive client-owned dogs (2006&#x02013;2007)</article-title>. <source>Vet J.</source> (<year>2013</year>) <volume>198</volume>:<fpage>690</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.tvjl.2013.09.067</pub-id><pub-id pub-id-type="pmid">24215779</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Boon</surname> <given-names>J</given-names></name></person-group>. <source>Veterinary Echocardiography.</source> <edition>2nd ed</edition>. <publisher-loc>Hoboken</publisher-loc>: <publisher-name>Wiley-Blackwell</publisher-name> (<year>2010</year>).</citation>
</ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vahanian</surname> <given-names>A</given-names></name> <name><surname>Beyersdorf</surname> <given-names>F</given-names></name> <name><surname>Praz</surname> <given-names>F</given-names></name> <name><surname>Milojevic</surname> <given-names>M</given-names></name> <name><surname>Baldus</surname> <given-names>S</given-names></name> <name><surname>Bauersachs</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)</article-title>. <source>Eur J Cardiothorac Surg.</source> (<year>2021</year>) <volume>60</volume>:<fpage>727</fpage>&#x02013;<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1093/ejcts/ezab557</pub-id><pub-id pub-id-type="pmid">35024822</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bristow</surname> <given-names>P</given-names></name> <name><surname>Sargent</surname> <given-names>J</given-names></name> <name><surname>Luis Fuentes</surname> <given-names>V</given-names></name> <name><surname>Brockman</surname> <given-names>D</given-names></name></person-group>. <article-title>Outcome of bioprosthetic valve replacement in dogs with tricuspid valve dysplasia</article-title>. <source>J Small Anim Pract.</source> (<year>2017</year>) <volume>58</volume>:<fpage>205</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1111/jsap.12630</pub-id><pub-id pub-id-type="pmid">28276122</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bristow</surname> <given-names>P</given-names></name> <name><surname>Kurosawa</surname> <given-names>A</given-names></name> <name><surname>Fuentes</surname> <given-names>VL</given-names></name> <name><surname>Rutherford</surname> <given-names>L</given-names></name> <name><surname>Brockman</surname> <given-names>D</given-names></name></person-group>. <article-title>Surgical valvulotomy for tricuspid valve stenosis in a dog</article-title>. <source>J Vet Cardiol.</source> (<year>2019</year>) <volume>23</volume>:<fpage>142</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jvc.2019.04.002</pub-id><pub-id pub-id-type="pmid">31174724</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sutherland</surname> <given-names>BJ</given-names></name> <name><surname>Pierce</surname> <given-names>KV</given-names></name> <name><surname>Heffner</surname> <given-names>GG</given-names></name> <name><surname>Scansen</surname> <given-names>BA</given-names></name> <name><surname>Miller</surname> <given-names>MW</given-names></name> <name><surname>Grey</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Surgical repair for canine tricuspid valve dysplasia: technique and case report</article-title>. <source>J Vet Cardiol.</source> (<year>2021</year>) <volume>33</volume>:<fpage>34</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.jvc.2020.11.001</pub-id><pub-id pub-id-type="pmid">33279771</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serres</surname> <given-names>F</given-names></name> <name><surname>Chetboul</surname> <given-names>V</given-names></name> <name><surname>Gouni</surname> <given-names>V</given-names></name> <name><surname>Tissier</surname> <given-names>R</given-names></name> <name><surname>Sampedrano</surname> <given-names>CC</given-names></name> <name><surname>Pouchelon</surname> <given-names>JL</given-names></name></person-group>. <article-title>Diagnostic value of echo-Doppler and tissue Doppler imaging in dogs with pulmonary arterial hypertension</article-title>. <source>J Vet Intern Med.</source> (<year>2007</year>) <volume>21</volume>:<fpage>1280</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/j.1939-1676.2007.tb01950.x</pub-id><pub-id pub-id-type="pmid">18196738</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pellikka</surname> <given-names>PA</given-names></name> <name><surname>Tajik</surname> <given-names>AJ</given-names></name> <name><surname>Khandheria</surname> <given-names>BK</given-names></name> <name><surname>Seward</surname> <given-names>JB</given-names></name> <name><surname>Callahan</surname> <given-names>JA</given-names></name> <name><surname>Pitot</surname> <given-names>HC</given-names></name> <etal/></person-group>. <article-title>Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients</article-title>. <source>Circulation.</source> (<year>1993</year>) <volume>87</volume>:<fpage>1188</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.87.4.1188</pub-id><pub-id pub-id-type="pmid">7681733</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Venco</surname> <given-names>L</given-names></name> <name><surname>Mihaylova</surname> <given-names>L</given-names></name> <name><surname>Boon</surname> <given-names>JA</given-names></name></person-group>. <article-title>Right pulmonary artery distensibility index (RPAD Index). A field study of an echocardiographic method to detect early development of pulmonary hypertension and its severity even in the absence of regurgitant jets for Doppler evaluation in heartworm-infected dogs</article-title>. <source>Vet Parasitol.</source> (<year>2014</year>) <volume>206</volume>:<fpage>60</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetpar.2014.08.016</pub-id><pub-id pub-id-type="pmid">25218885</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname> <given-names>YY</given-names></name> <name><surname>Ward</surname> <given-names>JL</given-names></name> <name><surname>Barron</surname> <given-names>LZ</given-names></name> <name><surname>Murphy</surname> <given-names>SD</given-names></name> <name><surname>Tropf</surname> <given-names>MA</given-names></name> <name><surname>Lisciandro</surname> <given-names>GR</given-names></name> <etal/></person-group>. <article-title>Focused ultrasound of the caudal vena cava in dogs with cavitary effusions or congestive heart failure: a prospective, observational study</article-title>. <source>PLoS ONE.</source> (<year>2021</year>) <volume>16</volume>:<fpage>e0252544</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0252544</pub-id><pub-id pub-id-type="pmid">34048483</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mizuno</surname> <given-names>T</given-names></name> <name><surname>Mizuno</surname> <given-names>M</given-names></name> <name><surname>Harada</surname> <given-names>K</given-names></name> <name><surname>Takano</surname> <given-names>H</given-names></name> <name><surname>Shinoda</surname> <given-names>A</given-names></name> <name><surname>Takahashi</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Surgical correction for sinus venosus atrial septal defect with partial anomalous pulmonary venous connection in a dog</article-title>. <source>J Vet Cardiol.</source> (<year>2020</year>) <volume>28</volume>:<fpage>23</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.jvc.2020.01.006</pub-id><pub-id pub-id-type="pmid">32182571</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dietz</surname> <given-names>MF</given-names></name> <name><surname>Prihadi</surname> <given-names>EA</given-names></name> <name><surname>van der Bijl</surname> <given-names>P</given-names></name> <name><surname>Goedemans</surname> <given-names>L</given-names></name> <name><surname>Mertens</surname> <given-names>BJA</given-names></name> <name><surname>Gursoy</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Prognostic implications of right ventricular remodeling and function in patients with significant secondary tricuspid regurgitation</article-title>. <source>Circulation.</source> (<year>2019</year>) <volume>140</volume>:<fpage>836</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.119.039630</pub-id><pub-id pub-id-type="pmid">31185724</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dietz</surname> <given-names>MF</given-names></name> <name><surname>Prihadi</surname> <given-names>EA</given-names></name> <name><surname>van der Bijl</surname> <given-names>P</given-names></name> <name><surname>Ajmone Marsan</surname> <given-names>N</given-names></name> <name><surname>Delgado</surname> <given-names>V</given-names></name> <name><surname>Bax</surname> <given-names>JJ</given-names></name></person-group>. <article-title>Prognostic implications of staging right heart failure in patients with significant secondary tricuspid regurgitation</article-title>. <source>JACC Heart Fail.</source> (<year>2020</year>) <volume>8</volume>:<fpage>627</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.jchf.2020.02.008</pub-id><pub-id pub-id-type="pmid">32535118</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feldh&#x000FC;tter</surname> <given-names>EK</given-names></name> <name><surname>Domenech</surname> <given-names>O</given-names></name> <name><surname>Vezzosi</surname> <given-names>T</given-names></name> <name><surname>Tognetti</surname> <given-names>R</given-names></name> <name><surname>Sauter</surname> <given-names>N</given-names></name> <name><surname>Bauer</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Echocardiographic reference intervals for right ventricular indices, including 3-dimensional volume and 2-dimensional strain measurements in healthy dogs</article-title>. <source>J Vet Intern Med.</source> (<year>2022</year>) <volume>36</volume>:<fpage>8</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1111/jvim.16331</pub-id><pub-id pub-id-type="pmid">34874066</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uechi</surname> <given-names>M</given-names></name> <name><surname>Mizukoshi</surname> <given-names>T</given-names></name> <name><surname>Mizuno</surname> <given-names>T</given-names></name> <name><surname>Mizuno</surname> <given-names>M</given-names></name> <name><surname>Harada</surname> <given-names>K</given-names></name> <name><surname>Ebisawa</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Mitral valve repair under cardiopulmonary bypass in small-breed dogs: 48 cases (2006-2009)</article-title>. <source>J Am Vet Med Assoc.</source> (<year>2012</year>) <volume>240</volume>:<fpage>1194</fpage>&#x02013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.2460/javma.240.10.1194</pub-id><pub-id pub-id-type="pmid">22559109</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mizuno</surname> <given-names>T</given-names></name> <name><surname>Mizukoshi</surname> <given-names>T</given-names></name> <name><surname>Uechi</surname> <given-names>M</given-names></name></person-group>. <article-title>Long-term outcome in dogs undergoing mitral valve repair with suture annuloplasty and chordae tendinae replacement</article-title>. <source>J Small Anim Pract.</source> (<year>2013</year>) <volume>54</volume>:<fpage>104</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1748-5827.2012.01305.x</pub-id><pub-id pub-id-type="pmid">23146131</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aoyagi</surname> <given-names>S</given-names></name> <name><surname>Tanaka</surname> <given-names>K</given-names></name> <name><surname>Hara</surname> <given-names>H</given-names></name> <name><surname>Kumate</surname> <given-names>M</given-names></name> <name><surname>Oryoji</surname> <given-names>A</given-names></name> <name><surname>Yasunaga</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Modified De Vega&#x00027;s annuloplasty for functional tricuspid regurgitation&#x02013;early and late results</article-title>. <source>Kurume Med J.</source> (<year>1992</year>) <volume>39</volume>:<fpage>23</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">1619886</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>X</given-names></name> <name><surname>Gu</surname> <given-names>C</given-names></name> <name><surname>Li</surname> <given-names>B</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Yang</surname> <given-names>J</given-names></name> <name><surname>Wei</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Midterm clinical and echocardiographic results of a modified De Vega tricuspid annuloplasty for repair of functional tricuspid regurgitation</article-title>. <source>Can J Cardiol.</source> (<year>2013</year>) <volume>29</volume>:<fpage>1637</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.cjca.2013.05.015</pub-id><pub-id pub-id-type="pmid">24011799</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>S&#x000E1;nchez-Esp&#x000ED;n</surname> <given-names>G</given-names></name> <name><surname>Rodr&#x000ED;guez-Capit&#x000E1;n</surname> <given-names>J</given-names></name> <name><surname>Otero Forero</surname> <given-names>JJ</given-names></name> <name><surname>Becerra Mu&#x000F1;oz</surname> <given-names>VM</given-names></name> <name><surname>Rodr&#x000ED;guez Caulo</surname> <given-names>EA</given-names></name> <etal/></person-group>. <article-title>Outcomes of isolated tricuspid valve surgery</article-title>. <source>Heart Surg Forum.</source> (<year>2020</year>) <volume>23</volume>:<fpage>E763</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.2739/kurumemedj.39.23</pub-id><pub-id pub-id-type="pmid">1619886</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sohn</surname> <given-names>SH</given-names></name> <name><surname>Kim</surname> <given-names>KH</given-names></name> <name><surname>Lee</surname> <given-names>Y</given-names></name> <name><surname>Choi</surname> <given-names>JW</given-names></name> <name><surname>Hwang</surname> <given-names>HY</given-names></name></person-group>. <article-title>Long-term outcomes of rigid ring versus De Vega annuloplasty for functional tricuspid regurgitation: a propensity score-matching analysis</article-title>. <source>J Thorac Cardiovasc Surg.</source> (<year>2021</year>) <volume>161</volume>:<fpage>1788</fpage>&#x02013;<lpage>98.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtcvs.2019.11.049</pub-id><pub-id pub-id-type="pmid">31948739</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname> <given-names>HY</given-names></name> <name><surname>Chang</surname> <given-names>HW</given-names></name> <name><surname>Jeong</surname> <given-names>DS</given-names></name> <name><surname>Ahn</surname> <given-names>H</given-names></name></person-group>. <article-title>De Vega annuloplasty for functional tricuspid regurgitation: concept of tricuspid valve orifice index to optimize tricuspid valve annular reduction</article-title>. <source>J Korean Med Sci.</source> (<year>2013</year>) <volume>28</volume>:<fpage>1756</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.3346/jkms.2013.28.12.1756</pub-id><pub-id pub-id-type="pmid">24339705</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Revuelta</surname> <given-names>JM</given-names></name> <name><surname>Garcia-Rinaldi</surname> <given-names>R</given-names></name></person-group>. <article-title>Segmental tricuspid annuloplasty: a new technique</article-title>. <source>J Thorac Cardiovasc Surg.</source> (<year>1989</year>) <volume>97</volume>:<fpage>799</fpage>&#x02013;<lpage>801</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-5223(19)34529-5</pub-id><pub-id pub-id-type="pmid">17258025</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishida</surname> <given-names>M</given-names></name> <name><surname>Kagawa</surname> <given-names>Y</given-names></name> <name><surname>Mizukoshi</surname> <given-names>T</given-names></name> <name><surname>Mizuno</surname> <given-names>M</given-names></name> <name><surname>Mizuno</surname> <given-names>T</given-names></name> <name><surname>Harada</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Post-mortem evaluation of expanded polytetrafluoroethylene (ePTFE) used in mitral valve repair in dogs</article-title>. <source>J Vet Cardiol.</source> (<year>2012</year>) <volume>14</volume>:<fpage>307</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.jvc.2011.11.004</pub-id><pub-id pub-id-type="pmid">22361171</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Calvert</surname> <given-names>CA</given-names></name></person-group>. <article-title>Treatment of heartworm disease with associated severe pulmonary arterial disease</article-title>. In: <source>Proceedings of the Heartworm Symposium&#x00027;86.</source> <publisher-loc>New Orleans</publisher-loc>: <publisher-name>American Heartworm Society</publisher-name> (<year>1986</year>). p. <fpage>125</fpage>&#x02013;<lpage>9</lpage>.</citation>
</ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Falc&#x000F3;n-Cord&#x000F3;n</surname> <given-names>Y</given-names></name> <name><surname>Montoya-Alonso</surname> <given-names>JA</given-names></name> <name><surname>Caro-Vadillo</surname> <given-names>A</given-names></name> <name><surname>Matos-Rivero</surname> <given-names>JI</given-names></name> <name><surname>Carret&#x000F3;n</surname> <given-names>E</given-names></name></person-group>. <article-title>Persistence of pulmonary endarteritis in canine heartworm infection 10 months after the eradication of adult parasites of Dirofilaria immitis</article-title>. <source>Vet Parasitol.</source> (<year>2019</year>) <volume>273</volume>:<fpage>1</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetpar.2019.07.008</pub-id><pub-id pub-id-type="pmid">31442886</pub-id></citation></ref>
</ref-list> 
</back>
</article>